Pacific Capital Partners LTD Eli Lilly & CO Transaction History

Pacific Capital Partners LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 May 08, 2025	BUY	$727.2 - $932.06 $906,091 - $1.16 Million	1,246 New	1,246 $962 Million
Q3 2024 May 08, 2025	BUY	$772.14 - $960.02 $962,086 - $1.2 Million	1,246 New	1,246 $1.1 Billion
Q4 2023 May 08, 2025	BUY	$525.19 - $619.13 $11,554 - $13,620	22 Added 1.8%	1,246 $726 Million
Q3 2023 May 08, 2025	BUY	$434.7 - $599.3 $532,072 - $733,543	1,224 New	1,224 $657 Million

4,523

754M

14.8M

16.9M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $971B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Pacific Capital Partners LTD, based on Form 13F filings with the SEC.

Stay updated on Pacific Capital Partners LTD with notifications on news.